Posted on October 04, 2014 in Drugs

Abilify is the name brand of the medication aripirazole. Aripirazole is the medicine used to treat mental disorders such as bipolar disorder, severe mental depression and schizophrenia. No evidence has been released that proves that the drug does not do what it is intended to do, but there are some unexpected side effects of taking this medication about which many patients have filed lawsuits. These unexpected side effects primarily include the development or exacerbation of compulsive behavior, according to the British Journal of Psychology, sometimes in patients in whom compulsive behavior had not bee observed prior to taking Abilify.

When the drug first hit the market, the U.S. Food and Drug Administration (FDA) made no warnings that the medicine could induce compulsive behavior. According to the FDA, possible side effects of Abilify included high blood sugar and neuroleptic malignant syndrome (NMS). NMS can result in “high fever, stiff muscles, confusion, sweating, changes in pulse, heart rate, and blood pressure.” Because Abilify functions as an anti-depressant, the FDA also made note that the medicine could lead to increased thoughts of suicide during initial stages of being on the medication.

Continue Reading ››

 Posted on October 02, 2014 in Defective Medical Devices

Surgical mesh was developed in the mid-20th century as a way to treat hernias. The implant was originally intended to be placed beneath the skin to patch the hole in the abdomen and block intestines and other tissues from protruding, according to the U.S. Food and Drug Administration. It can be made from either biological or synthetic materials. Recently, manufacturers of surgical mesh began marketing it as a means to prevent organ prolapse into the vaginas of women. It can be implanted after a hysterectomy or as a separate procedure. Women often experience a weakening of pelvic muscles after pregnancy and childbirth, which can lead to organ prolapse. About one-third of surgeries performed to prevent organ prolapse in women in 2010 used transvaginal mesh as a means to prevent further prolapse.

It may seem a wonder procedure, but the procedure of implantation and the implant itself can have so many negative side effects it may not be the best cure. According to a Bloomberg wire article published in The Daily Record, one manufacturer, Endo Health Solutions Inc., was ordered earlier this year to pay $830 million in damages to resolve lawsuits brought against it by women who had undergone a transvaginal mesh implant procedure. Women allege that the implant “failed to support internal organs and caused incontinence,” according to The Daily Record.

Continue Reading ››

 Posted on September 29, 2014 in Arlington Heights Defective Medical Device Attorney

A recent report shows the number of recalled medical devices continuing to increase. In response, many watchdog and consumer protection groups are aiming to make stricter requirements for medical devices.

A “cadre of insurers and other healthcare stakeholders” is urging the U.S. Food and Drug Administration (FDA) to “establish more registries to monitor and report performance” of medical devices being used in the U.S. market, according to MassDevice.com.

This cadre is requesting that the medtech registries be updated to enable more detailed information-gathering on devices that have been cleared or approved. Hence, this would help to ensure that complications resulting from the use or implementation of a faulty device would be recorded as soon as possible. This could help alleviate scenarios in which faulty medical devices are used, even after the first reports of failure.

Continue Reading ››

 Posted on September 24, 2014 in Defective Medical Devices

When complicated medical technology hits the market and is adopted by medical professionals, issues with associated surgeries are bound to occur. There are several reasons for this, and difficulties with the manufacturing of the product itself are not the only ones. By some reports, the U.S. Food and Drug Administration (FDA) does not always fully vet products before they are released to the public. Hence, many devices end up recalled. According to The Wall Street Journal, the number of recalled devices continues to increase each year, and have in fact increased by almost 50 percent between 2003 and 2012.

Manufacturer recalls, not mandated by the FDA, often come too late to those who have already used the recalled device. One such example occurred in 2007 via the Metronic recall of defibrillator wires. These wires had been implanted in more than a quarter-million patients before the recall was issued, and thus resulted in a handful of patient deaths. However, Wanda Moebius, a senior vice president at the industry trade group AdvaMed, told The Wall Street Journal that medical device companies are taking a more patient-centric and cautious approach to FDA reporting.

Continue Reading ››

 Posted on September 19, 2014 in Defective Prescription Drugs

Products liability covers a large range of products and can include intangible property such as pets, gas leaks, and real estate. Defective medical products are one of the most damaging types of products liability. Examples of defective medical products include those that were not fully vetted for compatibility with the body, those with side effects more severe than the disease they are supposed to alleviate, and those that cause unexpected additional issues for the patient. Product liability for defective medical products does not only refer to the product itself, but also to the way in which the product was distributed and used.

According to the Legal Information Institute at the Cornell University Law School, there are three main types of product defects. These include design defects, manufacturing defects, and marketing defects. A defect in marketing, in regards to a medical device, includes instructions for patient use.

Continue Reading ››

 Posted on September 15, 2014 in Defective Medical Devices

In August, two U.S. senators began pressing the Food and Drug Administration (FDA) to take power morcellators off the American medical device market. According to the FDA, laparoscopic power morcellators are used to help remove tissue through small incision sites, and are most commonly used in hysterectomies or during the surgical removal of uterine fibroids (myomectomy).

The FDA clearly states that when used for either purpose, the morcellators “poses a risk of spreading unsuspected cancerous tissue” beyond the uterus and into the bloodstream. As such, the agency discourages the use of morcellators but does not outright forbid their implementation. This is what New York Senators Chuck Schumer and Kirsten Gillibrand are attempting to quell.

According to an article in Modern Heathcare, in August Senators Schumer and Gillibrand wrote a letter to the FDA requesting that the agency to remove the morcellator devices from the market. The letter, reports Modern Healthcare, cites a recent survey done at Boston's Brigham and Women's Hospital which found that women who had morcellators implemented were at a nine times higher risk of having the cancer spread than what was communicated to them at the time of surgery.

Continue Reading ››

 Posted on September 12, 2014 in Defective Prescription Drugs

When the antidepressant drug Paxil hit the consumer market in the early 1990s, it was hailed by the medical world as a wonder drug, able to relieve even the most severe cases of mental depression. Like most other antidepressants, Paxil is a selective serotonin reuptake inhibitor (SSRI). There have been widely-publicized side effects about SSRIs for the patient who takes them. However, not as much has been published about the effects SSRIs can have on babies born to women who are taking them.

According to the U.S. Food and Drug Administration (FDA), the first such warning was in fact issued as early as 2005, when the FDA advised the medical community to discontinue the practice of prescribing Paxil to pregnant women. In 2005, however, the FDA maintained that women who were already on Paxil may face a greater risk to the fetus by discontinuing the medication than by continuing to take it.

This has changed. According to a recent article in The New York Times, the risk of taking SSRIs during pregnancy could be far worse for the fetus than the risk of being depressed. Women, reports the The New York Times, go to great lengths to give their baby the best start to life: they often quit smoking, give up drinking, and decline foods like Brie cheese and swordfish. Yet these same women often do not give up SSRIs, “despite an increasing number of studies linking prenatal exposure to birth defects, complications after birth, and even developmental delays and autism.” A recent study out of John Hopkins University found that young boys with autism were more than 30 percent more likely to have been exposed to SSRIs via their mother during prenatal development.

Continue Reading ››

 Posted on September 09, 2014 in Defective Prescription Drugs

The U.S. Food and Drug Administration (FDA) recently issued a warning to physicians across the country not to use any compounded drugs that were manufactured by Unique Pharmaceuticals because of possible contamination. This action was done in response to an FDA inspection of the company's Temple, Texas manufacturing plant, where inspectors found issues with medication production that may have compromised the sterility of the medication.

Unique Pharmaceutical issued a voluntary recall of all its sterile compounded medications that have not yet expired and are advising that all products be returned to the company. The products were contained in vials, bags and syringes. Non-sterile items manufactured by the company are not affected by the recall. In the warning to consumers, the FDA said that patients who use sterile items that may have been contaminated are at risk of serious and possibly fatal infections.

Compounding pharmacies manufacture customized medications that have been ordered by doctors. According to the International Academy of Compounding Pharmacists (IACP), out of the almost 56,000 compounding pharmacies in the country, approximately 7,500 offer “advanced compounding services.” About 3,000 of them manufacture sterile products.

Continue Reading ››

 Posted on September 05, 2014 in Testosterone Therapy

Testosterone therapy entices its users with the promise of increased muscle mass, boosted libido, increased energy levels, and sharpened concentration and memory. As men age, they begin to see testosterone therapy as a viable option to help them get back some of their youth. Testosterone therapy involves the taking of testosterone medicines to increase one's testosterone levels. However, as the different types of testosterone therapy products on the market increase, so has the increase in defective drug claims.

In Illinois, testosterone therapy claims were filed earlier this year, and many believe that there are many more on the way. Some of the many arguments from plaintiffs have been that they were insufficiently warned about the serious risks associated with testosterone therapy. These risks include blood clots, heart attacks, and strokes. More specifically, these suits argue that testosterone manufacturers and producers have created deceptive and aggressive product marketing campaigns in order to entice consumers to engage in testosterone therapy. Furthermore, testosterone therapy products pose a particular problem for diabetics. Such therapies dramatically decreased blood sugar levels, which, for a diabetic, can cause rapid heartbeat, dizziness and blurred vision.

Continue Reading ››

 Posted on August 29, 2014 in Defective Medical Devices

Bayer Healthcare Pharmaceuticals, a manufacturer of Mirena Intrauterine Devices (IUD) birth control, has faced several lawsuits in recent years for alleged complications that arise from having used the device. Earlier this month, Mirena made headlines in Bergen County, New Jersey, where nearly 1,000 new lawsuits were filed to date against the manufacturer. The lawsuits allege serious injuries due to “spontaneous migration of the IUD” in those who had the device implanted. Noted injuries include “uterine perforations, organ damage, scarring, and infertility.” There are an additional 600 similar lawsuits pending in southern New York.

An intrauterine device is a long-term contraceptive that is implanted into a woman's uterus. It can only be implanted by a certified medical provider, and has been in use since it was approved by the Food and Drug Administration (FDA) in 2000. It was not until nine years later that the device was approved for use in women with extreme heavy menstrual bleeding. That same year, however, the FDA warned Bayer that their promotion of the intrauterine device did not adequately warn patients of the risks and overstated the benefits of using this type of birth control.

Continue Reading ››